NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

"they are attempting to educate us, their colleagues and regulators that immunotherapy is different, and a strong tail of 25% or more with near cure results is sometimes better than say a couple months improvement in mPFS or mOS."
---------------------------------------------------------------------------

You are talking about the no-effect that a 25% cure rate could have on median efficacy... while being a huge step forward...

But weren't some the checkpoint modulator clinical results of that shape, and yet did gain approval? Maybe for malignant melanoma.